Sirio Pharma Co., Ltd. (SHE:300791)

China flag China · Delayed Price · Currency is CNY
19.16
+0.04 (0.21%)
May 8, 2026, 3:04 PM CST
Market Cap5.88B +7.2%
Revenue (ttm)4.31B +7.9%
Net Income117.80M +2.9%
EPS0.39 +2.7%
Shares Out307.02M
PE Ratio42.88
Forward PE15.77
Dividend0.13 (0.68%)
Ex-Dividend DateMay 27, 2025
Volume1,222,412
Average Volume2,029,017
Open19.12
Previous Close19.12
Day's Range19.08 - 19.24
52-Week Range18.70 - 28.19
Beta0.29
RSI38.12
Earnings DateApr 24, 2026

About Sirio Pharma

Sirio Pharma Co., Ltd. operates as a contract manufacturer for dietary supplement industry worldwide. The company develops and manufactures a range of softgel dietary supplements; vegetarian softgel; nutritious gummies; probiotic balls; tablet and powder products; capsules; and functional beverages. It also offers a range of services, including primary and final packaging. Sirio Pharma Co., Ltd. was founded in 1993 and is based in Shantou, China. [Read more]

Founded 1993
Employees 2,776
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300791
Full Company Profile

Financial Performance

In 2024, Sirio Pharma's revenue was 4.21 billion, an increase of 17.56% compared to the previous year's 3.58 billion. Earnings were 325.06 million, an increase of 15.66%.

Financial Statements